SWISS PHARMA RESEARCH LABORATORY INCORPORATED
Filipino-Swiss joint venture (founded 1979) providing CGMP-compliant contract manufacturing of pharmaceuticals, cosmetics, and food supplements in the Philippines, serving multinational drug firms and local distributors with manufacturing, analytical, R&D, and regulatory services from its Cabuyao, Laguna facility.
- Company typePrivate
- Founded1979
- HeadquartersManila, Philippines
- Headcount11–50
- GTM typeB2B
- OfferingServices
What SWISS PHARMA RESEARCH LABORATORY INCORPORATED does
Swisspharma Research Laboratories, Inc. (SPRLI) is a Filipino-Swiss joint venture founded in 1979 that operates as a contract manufacturer of pharmaceutical products, cosmetics, and food supplements in the Philippines. Its core manufacturing capabilities span production and packaging of tablets (conventional and modified release), capsules, liquids (syrups, suspensions, emulsions), powders for suspension, creams, ointments, and cosmetic products, executed on equipment including the Glatt GPCG 3.1 fluidized-bed granulation and coating system and the PR 200 fully automatic tableting machine, with ISBT 128 barcoding for sample traceability. The company holds Class A1 accreditation from the Philippine DOH/FDA and WHO and US-FDA-aligned CGMP certification, and operates from a single integrated Cabuyao, Laguna manufacturing facility with in-house analytical laboratory, R&D, regulatory services, climate-controlled warehouse, and water and wastewater treatment infrastructure.
The business model is B2B contract manufacturing and related services, with revenue generated through quote-based manufacturing contracts for multinational drug firms and local pharmaceutical drug traders and distributors, serving both export and domestic Philippine markets. GTM is enterprise field sales supported by regional offices in Luzon (Manila), Visayas (Cebu/Mandaue), and Mindanao (Davao), and complemented by memberships in industry associations including the Philippine Pharmaceutical and Health Care Association and the Chamber of Filipino Drug Manufacturers and Distributors. Beyond the core contract manufacturing franchise, SPRLI has extended into adjacent product lines through sub-brands (Le Gab Ventures, The Brew and Mixes, Glaze and Glory) and operates the Biohellenika Cell Therapy Centre as a wholly-owned subsidiary offering cell therapy and clinical laboratory services from within the Cabuyao facility.
SWISS PHARMA RESEARCH LABORATORY INCORPORATED firmographics
Firmographics- Name
- SWISS PHARMA RESEARCH LABORATORY INCORPORATED
- Legal name
- Swisspharma Research Laboratories, Inc.
- Website
- https://sprli.com.ph
- Company type
- Private
- Founded year
- 1979
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Filipino-Swiss joint venture (founded 1979) providing CGMP-compliant contract manufacturing of pharmaceuticals, cosmetics, and food supplements in the Philippines, serving multinational drug firms and local distributors with manufacturing, analytical, R&D, and regulatory services from its Cabuyao, Laguna facility.
- Ownership category
- akta.pro rank
Where SWISS PHARMA RESEARCH LABORATORY INCORPORATED is headquartered
LocationHeadquarters
- HQ city
- Manila
- HQ country
- Philippines
- HQ region
- Asia
Offices4 records
Markets served
SWISS PHARMA RESEARCH LABORATORY INCORPORATED business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales
Revenue model
- Contract Manufacturing: Contract manufacturing of pharmaceutical products, cosmetics, and food supplements for multinational drug firms and local pharmaceutical drug traders and distributors. Revenue generated through manufacturing service contracts for international and local markets.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
SWISS PHARMA RESEARCH LABORATORY INCORPORATED product offering
Product offeringCore offering
Swisspharma Research Laboratories, Inc. (SPRLI) is a Filipino-Swiss joint venture providing contract manufacturing of pharmaceutical products, cosmetics, and food supplements for international and local markets. The company operates CGMP-compliant production of tablets, capsules, liquids, powders, creams, and ointments, complemented by analytical laboratory, R&D, regulatory, warehouse, and engineering services from its Cabuyao, Laguna manufacturing facility.
Product overview
Swiss Pharma Research Laboratories, Inc. (SPRLI) is a Filipino-Swiss joint venture offering a comprehensive portfolio of contract manufacturing and laboratory services for the pharmaceutical, cosmetics, and food supplement industries. The core offering centers on Manufacturing Services (tablets, capsules, liquids, creams/ointments production and packaging), complemented by Analytical Laboratory Services (microbiological, environmental, chemical testing using HPLC, GC, FTIR), Research and Development Services (formulation, granulation, and coating using Glatt GPCG 3.1), Regulatory Services (FDA product registration, ACTD/ACTR compliance), Warehouse Services (climate-controlled storage), Engineering Services (water/wastewater treatment), and Diagnostic Laboratory Services. The company also operates the Biohellenika Cell Therapy Centre for advanced cell-based therapies. All operations adhere to CGMP standards meeting WHO and US-FDA requirements.
Differentiator
Problem solved
Functional benefit
Brands
- Biohellenika: Cell Therapy Centre located inside Swisspharma facilities at Barrio Pittland, Cabuyao, Laguna, Philippines, offering clinical laboratory services.
Products and services
- Contract Manufacturing Services Contract manufacturing of pharmaceutical products, cosmetics, and food supplements for international and local markets, employing state-of-the-art technology and GMP standards. Production and packaging of tablets (conventional and modified release), capsules (conventional and modified release), liquids (syrups, suspension and emulsions), powder for suspension, creams, ointments, and cosmetic products.
- Analytical Laboratory Services General testing for microbiological, environmental, and chemical analysis including water testing, vitamins and minerals content. Assay and substance identification using HPLC, Gas Chromatography, UV-Vis, FTIR, Thin Layer Chromatography, and various titration and spectrophotometric methods.
- Research and Development Services Product development including formulation, manufacturing/compounding, and reformulation for syrup, suspension, PFS, tablets, capsules, creams, and lotions. Granulation and coating services using the Glatt GPCG 3.1 machine for instant release, enteric coating, and modified release applications.
- Regulatory Services Product registration assistance and technical documents preparation for pharmaceuticals and non-pharmaceuticals, including ACTD/ACTR compliance, stability data, analytical method validation, and process validation.
- Warehouse Services Storage facilities including special rooms with controlled temperature and low relative humidity, air-conditioned rooms for heat-sensitive raw materials and bulk/finished goods.
- Engineering Services Water treatment for process water, wastewater treatment, dust collection system, and tools fabrication services supporting manufacturing operations.
- Biohellenika Cell Therapy Centre State-of-the-art clinical laboratory providing cell therapy services including stem cell transplants and CAR T-cell therapies, located inside Swisspharma facilities at Barrio Pittland, Cabuyao, Laguna, Philippines, using ISBT 128 barcoding for sample traceability and network IP security camera systems.
- Diagnostic Laboratory Services Diagnostic laboratory services offered within the Swisspharma facilities, providing clinical testing capabilities.
Companies that use SWISS PHARMA RESEARCH LABORATORY INCORPORATED
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
SWISS PHARMA RESEARCH LABORATORY INCORPORATED technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
SWISS PHARMA RESEARCH LABORATORY INCORPORATED partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered supporting.
- Philippine Pharmaceutical and Health Care AssociationsupportingIndustry association for pharmaceutical and healthcare companies in the Philippines. Swisspharma is committed to supporting the association's efforts in the pharmaceutical sector.
- Chamber of Filipino Drug Manufacturers and DistributorssupportingTrade organization representing Filipino drug manufacturers and distributors. SPRLI participates in chamber activities and industry development initiatives.
- Philippine Society of Cosmetic SciencesupportingProfessional society for cosmetic science professionals in the Philippines. SPRLI maintains membership to stay current with cosmetic industry developments.
- Philippine Chamber of Commerce and IndustrysupportingNational chamber representing Philippine businesses across industries. SPRLI participates in chamber initiatives for business development.
- Laguna Chamber of Commerce and IndustrysupportingRegional chamber representing businesses in Laguna province where SPRLI manufacturing facility is located.
- Canlubang Industrial Estate AssociationsupportingAssociation of industrial companies in the Canlubang area, Laguna. SPRLI operates in proximity to this industrial zone.
- European Chamber of Commerce of the PhilippinessupportingBilateral chamber facilitating European-Philippine business relations. Relevant given SPRLI's Filipino-Swiss joint venture structure.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
SWISS PHARMA RESEARCH LABORATORY INCORPORATED competitors and assessment
Company assessmentDirect peers
- Siegfried Holding AG: Swiss-headquartered pharmaceutical CDMO offering API and drug product manufacturing services globally. Directly comparable to SPRLI given the Filipino-Swiss joint venture structure and the shared Swiss pharma heritage plus active contract manufacturing model for multinational pharma clients.
- Hovione: Portugal-based global CDMO specializing in oral dosage forms, sterile manufacturing, and complex formulations including modified-release products. Comparable to SPRLI's contract manufacturing services, particularly for modified-release and granulation capabilities enabled by its Glatt GPCG 3.1.
- Lloyd Laboratories, Inc. Philippines-based pharmaceutical manufacturer producing tablets, capsules, liquids, ointments and other dosage forms under GMP. Direct peer to SPRLI in the Philippine contract manufacturing and dosage form production space, including competing for local distributor and multinational client contracts.
- Scigen Pharma Limited: Philippines-based pharmaceutical manufacturer offering branded generics and contract manufacturing services. Direct local peer to SPRLI serving the same Philippine pharmaceutical manufacturing market and competing for similar local and multinational contract volumes.
Broad incumbents
- Recipharm AB: European-headquartered CDMO providing contract manufacturing of pharmaceuticals in multiple dosage forms. Comparable to SPRLI's contract manufacturing services as a mid-sized CDMO serving multinational pharma clients with similar GMP-compliant operations.
- Eurofins Scientific SE: Global bioanalytical testing and pharmaceutical services group offering laboratory testing, regulatory support, and CDMO-related services. Comparable to SPRLI's analytical laboratory services (HPLC, GC, FTIR, microbiological testing) and regulatory services as a benchmark for laboratory services scale.
- Lonza Group AG: Swiss-headquartered global CDMO with extensive pharmaceutical manufacturing and a leading cell and gene therapy services franchise. Comparable to SPRLI's core CDMO business and especially relevant to Biohellenika's cell therapy operations as a benchmark for the cell therapy CDMO category.
- Catalent, Inc. Large US-headquartered global CDMO offering oral, injectable, and biologic contract manufacturing plus softgel and specialized technologies. Comparable to SPRLI's contract manufacturing for pharmaceuticals, capsules, and modified-release formulations as a global scale benchmark.
Emerging players
- WuXi STA (WuXi AppTec): China-based global CDMO offering contract development and manufacturing for small molecule APIs and drug products. Comparable to SPRLI's contract manufacturing services as an emerging large-scale Asian CDMO serving multinational pharma, with materially greater scale.
Regional players
- Interpharma Co., Ltd. Thailand-based pharmaceutical manufacturer producing generic and branded medicines for ASEAN markets. Regional ASEAN peer to SPRLI with comparable contract manufacturing capabilities and similar exposure to ASEAN harmonization trends, though operating in a different national market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
SWISS PHARMA RESEARCH LABORATORY INCORPORATED social profiles
Digital presenceSWISS PHARMA RESEARCH LABORATORY INCORPORATED compliance and trust
Trust signalCompliance3 records
SWISS PHARMA RESEARCH LABORATORY INCORPORATED financial estimates
Financial estimateRevenue estimate
Valuation estimate
SWISS PHARMA RESEARCH LABORATORY INCORPORATED leadership team
Management profileNumber of profiles
SWISS PHARMA RESEARCH LABORATORY INCORPORATED subsidiaries and ownership
Company hierarchySubsidiaries1 record
SWISS PHARMA RESEARCH LABORATORY INCORPORATED funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SWISS PHARMA RESEARCH LABORATORY INCORPORATED M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SWISS PHARMA RESEARCH LABORATORY INCORPORATED
What does SWISS PHARMA RESEARCH LABORATORY INCORPORATED do?
Swisspharma Research Laboratories, Inc. (SPRLI) is a Filipino-Swiss joint venture providing contract manufacturing of pharmaceutical products, cosmetics, and food supplements for international and local markets. The company operates CGMP-compliant production of tablets, capsules, liquids, powders, creams, and ointments, complemented by analytical laboratory, R&D, regulatory, warehouse, and engineering services from its Cabuyao, Laguna manufacturing facility.
Is SWISS PHARMA RESEARCH LABORATORY INCORPORATED a public or private company?
SWISS PHARMA RESEARCH LABORATORY INCORPORATED is a private company. It is classified as unknown and is currently operating.
When was SWISS PHARMA RESEARCH LABORATORY INCORPORATED founded?
SWISS PHARMA RESEARCH LABORATORY INCORPORATED was founded in 1979. It employs 11 to 50 people.
Where is SWISS PHARMA RESEARCH LABORATORY INCORPORATED based?
SWISS PHARMA RESEARCH LABORATORY INCORPORATED is headquartered in Manila, Philippines, in the Asia region.
How does SWISS PHARMA RESEARCH LABORATORY INCORPORATED make money?
One revenue line is on record: contract Manufacturing.
Who are SWISS PHARMA RESEARCH LABORATORY INCORPORATED's main competitors?
Direct peers on record are Siegfried Holding AG, Hovione, Lloyd Laboratories, Inc. and Scigen Pharma Limited. Broad incumbents are Recipharm AB, Eurofins Scientific SE, Lonza Group AG and Catalent, Inc.. WuXi STA (WuXi AppTec) is listed as an emerging player. Interpharma Co., Ltd. is listed as a regional player.
Does SWISS PHARMA RESEARCH LABORATORY INCORPORATED have an API?
No public API is recorded for SWISS PHARMA RESEARCH LABORATORY INCORPORATED.